The proven technology to invest wisely

USA Change Macroaxis User Registration

HomePortfoliosSolutionsTools

WelcomePerformance LandscapeEquity ScreenersInsider ScreenerEfficient FrontierCorrelationsRisk/Return Analysis

US Market Closed: May 26, 15:28 PM 2012

AMGN GILD BIIB CELG ALXN VRTX

NYSE 7,534 18.032

Processing
Collecting data for NKTR

Nektar quote and profile

Companies

Insiders

Advisers

More Actions
- Equity Search
- Advanced Search
- Market Screener
- Adviser Directory
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatility
- Import Equities

6.96

STOCK

^(0.04)

0.57%

4.07

Year To Date

10.83

6.85

Trading Day

7.02

Diversification Suggestion

Use Nektar to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier

1 Month Beta ..........

2.73

As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Nektar will likely underperform.

Check Current Nektar Correlation with Market

NKTR

AMEX

Nektar Therapeutics

Healthcare

Biotechnology

http://www.nektar.com

415. 482. 5300

Trade Nektar

Correlation

Report

Fundamentals

Current Valuation	644.43 M
Shares Outstanding	114.61 M
Number of Shares Shorted	20.54 M
Revenue	78.13 M

NASDAQ		0.07 %
SP 500		0.22 %
NYSE		0.24 %
NKTR		0.57 %

Check Alpha

Nektar Leadership

Howard Robin CEO and President and Director

Robert Chess Independent Chairman of the Board, MBA

Robert Medve Chief Medical Officer, Vice President

Gil Labrucherie Senior Vice President General Counsel, Secretary

Nektar Price and Market Media

The median price of Nektar for the period between Thu, Apr 26, 2012 and Sat, May 26, 2012 is 7.1 with a coefficient of variation of 4.89. The daily time series for the period is distributed with a sample standard deviation of 0.35, arithmetic mean of 7.1, and mean deviation of 0.25. The Stock received some media coverage during the period.

Nektar

Market

More...

Price Growth (%)

Timeline

Jefferies Starts Nektar Therapeutics (NKTR) at Buy

05/23/2012

More Nektar Headlines

Nektar Summary

Nektar Therapeutics [NKTR] is traded on American Stock Exchange in USA. It is located in San Francisco, CA and employs 423 people. The company currently falls under 'Small-Cap' category with current market capitalization of 797.69 M. Nektar Therapeutics conducts business under Healthcare sector and is part of Biotechnology industry. This company has 114.61 M outstanding shares of which 20.54 M shares are now shorted by private and institutional investors with about 20.5 trading days to cover.

Nektar Liquidity

NEKTAR THERAPEUTI currently holds about 382.11 M in cash with (133.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.33.

The company currently holds 228.85 M in liabilities with Debt to Equity (D/E) ratio of 1.41 which is about averege as compared to similar companies. Nektar Therapeutics has Current Ratio of 1.52 which is within standard range for the sector.

Check Nektar Probability Of Bankruptcy